/ Print /

LATEST

Watch list 2017: Top therapeutic areas
Watch list 2017: Top therapeutic areasFind out about the latest treatment and drug pipeline developments
Post-election top policy changes to watch in 2017
Post-election top policy changes to watch in 2017While every new year brings change, with Donald Trump elected to become the next president, managed healthcare executives will see more changes than usual in 2017.
Healthcare executive compensation changes to watch
Healthcare executive compensation changes to watchManaged care organizations may be the next target of value-based reimbursements, with bonus payments tied to the health of their company—and its members.
Can data analytics aid in end-of-life care decisions?When it comes to clinicians discussing end-of-life care with patients and their families, too often decisions must be made quickly. Here’s how data analytics can help.
Get your plan members to shop around for less-expensive careSome health plans are finding success with a new program that rewards patients for seeking out cheaper care.
Top pharmacy challenges of 2017
Top pharmacy challenges of 2017High drug prices continue to plague payers, but various contributing factors intensify the problem.
Will new autoimmune drugs address cost concerns?Find out what’s in the drug pipeline for autoimmune disease.
Top 10 articles for healthcare executives in 2016Managed Healthcare Executive's most popular articles this year shed light on the biggest areas of interest to managed care organizations. Read more.
How data analytics combats the opioid epidemicDeaths due to opioid abuse have risen sharply—and show no signs of leveling off. Here’s how data analytics can prevent abuse and diversion.
How hospitals are doing with the CJR program: CMS releases key dataWhile the second feed may not change providers’ actions in terms of the strategy they’re implementing for the Comprehensive Care for Joint Replacement program, the findings should change their expectations.